Matthew W. Mosconi

Matthew W. Mosconi

Matthew W Mosconi

Dr. Mosconi completed his Ph.D. in Clinical Psychology and an APA-approved Clinical Internship at the University of North Carolina – Chapel Hill. He then performed his postdoctoral training in developmental cognitive neuroscience and pediatric neuropsychology at the University of Illinois in Chicago. Dr. Mosconi joined the faculty in Psychiatry at the University of Illinois in Chicago from 2009-2011, moved onto the faculty at the University of Texas Southwestern Medical Center from 2011-2015, and joined the faculty at the University of Kansas in August, 2015. He currently is an Associate Professor of Psychology and Applied Behavioral Science, and Associate Scientist in the Life Span Institute. Dr. Mosconi’s research is focused on sensorimotor dysmaturation and underlying brain mechanisms in neurodevelopmental disorders, including autism spectrum disorder, Phelan-McDermid Syndrome, and FMR1 related disorders. His work has been supported by NIH (NIMH, NINDS, NICHD), the Department of Defense, Autism Speaks, the Phelan-McDermid Syndrome Foundation and the Once Upon A Time Foundation. He has published in multiple high impact journals including JAMA Psychiatry, the Journal of Neuroscience, Journal of Neurophysiology, Molecular Autism, NeuroImage and Biological Psychiatry. Dr. Mosconi serves on the editorial boards of the Journal of Autism and Developmental Disorders and Current Developmental Disorders Reports. He was the recipient of the International Society for Autism Research (INSAR) 2014 Young Investigator Award.


Contact Information

Research Interests

Dr. Mosconi’s research examines sensorimotor, cognitive and brain development in autism spectrum and related intellectual/developmental disorders, including Phelan-McDermid Syndrome and Fragile X Syndrome. He also currently is conducting studies on neurodegenerative disorders characterized by deterioration of sensorimotor skills, such as Fragile X-associated tremor/ataxia syndrome (FXTAS). The aim of this research program is to determine the brain mechanisms that contribute to sensorimotor and cognitive impairments in developmental disorders. This knowledge then may be used for multiple purposes: 1) To identify new behavioral and brain targets for the development of more precise and effective therapeutic approaches; 2) To generate translational biobehavioral markers that can measured in clinical trials validating new treatment approaches, and; 3) To create biobehavioral measures that may assist in more reliable identification approaches for young children with autism. Dr. Mosconi’s studies integrate quantitative behavioral measurements, neuropsychological assessment, and systems neuroscience techniques including functional MRI, diffusion tensor imaging (DTI), electromyography (EMG), electroencephalography (EEG), kinematic and kinetic analysis and oculomotor recording. He is accepting applications for new graduate students for the 2016-2017 academic year.

  • Autism, sensorimotor
  • cerebellum
  • functional MRI
  • EEG
  • child psychology
  • Fragile X
  • Phelan-McDermid Syndrome
  • Fragile X Associated Tremor/Ataxia Syndrome (FXTAS)
  • repetitive behaviors
  • insistence on sameness
  • clinical psychology